Drug Delivery

The following presentation was from BIO International, May 18-21, 2009 in Atlanta, Georgia. This session was a Breakout session on the Drug Delivery Track and led by Frost & Sullivan. The presentation opened the session with subsequent moderation of a panel discussion around drug delivery technologies and how they are being utilized to improve curr...

This issue based deliverable covers the opportunities in macromolecular drug delivery with a look into the industry challenges, drivers, restraints and technological trends.

This research service explores the market for drug delivery used for the treatment of ocular diseases in the Unites States of America. It analyzes the various challenges faced by pharmaceutical, biotech, and drug delivery companies, and the competitive advantages and disadvantages of their products in the market.

The research services deals with the a strategic insight in to the opportunity in the drug delivery markets especially pulmonary and transdermal segments in Europe. Market drivers, restraints, industry challenges, key trends, revenue forecasts and strategic recommendations are provided in detail.

This research service discusses technology and strategy trends relative to the drug delivery market. It provides overview snapshots and highlights of drug delivery technology sector topics for implant delivery, oral modified release, and nanobiotechnology. Also discussed are business strategy trends currently important in drug delivery relative to ...

The U.S. Transdermal Drug Delivery Market is a rapidly emerging field with revenue growth in pain management, hormone, cardiovascular, CNS among others. The current market is presently dominated by the pain management market but the CNS field is expected to generate the fastest growth with several new products on the market. Additionally active pat...

The U.S. Intranasal Drug Delivery Market is a rapidly emerging field with revenue growth in pain management, osteoporosis, vaccines and sexual dysfunction. The market is undergoing an identity change, moving from predominantly non-systemic delivery of allergy medications to systemic delivery of medications for a variety of diseases.

This report analyzes the U.S. emerging transdermal drug delivery technologies markets, for the forecast period 1999 to 2009. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Passive Patches Market, Transdermal Gel Products Market and Active Transdermal Systems Market. Each segment provides revenue forecasts, market shar...

This report analyzes the U.S. emerging pulmonary drug delivery technologies markets, for the forecast period 1999 to 2009. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Non-CFC Metered Dose Inhalers Market, Dry Powder Inhalers Market and Liquid Based Inhalers Market. Each segment provides revenue forecasts, market sh...